Скачать или смотреть CRI Announces 2025 Lloyd J. Old STARs: 5 Bold Innovators Driving the Future of Cancer Immunotherapy

The next leaders in the field of immunotherapy are here. Meet the 2025 class of Lloyd J. Old STARs, five rising scientific leaders whose high-risk, high-reward research is set to redefine cancer treatment. The Cancer Research Institute (CRI) is investing $1.25 million in each of these emerging stars to support their daring, paradigm-shifting research.

As Dr. E. John Wherry of CRI’s Scientific Advisory Council notes, this funding is like “putting some jet fuel in the tank” for the next generation of leaders in the field. This award empowers our STARs to pursue the most ambitious ideas that could one day lead to a world immune to cancer.

Learn more about the 2025 Lloyd J. Old STARs and their research on our website: https://www.cancerresearch.org/media-...

--
The Cancer Research Institute (CRI) is a nonprofit organization exclusively focused on advancing cancer immunotherapy through rigorous scientific research, global collaboration, and data-driven innovation. Since 1953, CRI has empowered researchers to uncover how the immune system can fight cancer - and helped transform bold scientific ideas into treatments.

Our mission is to create a world immune to cancer by driving scientific discovery, accelerating collaboration, and turning breakthroughs into life-saving treatments. Our work bridges the gap between discovery and patient impact, ensuring that scientific innovation translates into real-world treatments.

Cancer Research Institute is a registered 501(c)(3) nonprofit under EIN 13-1837442. Donations are tax-deductible to the fullest extent allowable under the law.